Pfizer To Seek Approval For COVID Vaccine Booster

Pfizer is seeking approval for a third COVID-19 vaccine dose, claiming it boosts protection against variants like Delta by increasing antibodies 5 to 10 times. The company plans to submit emergency authorization paperwork soon. The Delta variant poses a challenge as it can bypass some antibodies, reducing vaccine effectiveness. However, full vaccination significantly enhances immunity. The rise in COVID-19 cases is partly due to unvaccinated individuals, according to health officials.

What is Pfizer's recommendation regarding the third dose of the COVID-19 vaccine?

• To get it only if traveling internationally

• To get it only if exposed to the Delta variant

• To get it within 12 months of the last dose

• To get it within 6 months of the last dose

How does the Delta variant affect the effectiveness of COVID-19 vaccines?

• It enhances the vaccine's effectiveness

• It has no impact on the vaccine's effectiveness

• It can bypass certain antibodies and reduce effectiveness

• It completely nullifies the vaccine's protection

What did French researchers discover about the Delta variant?

• It can bypass certain antibodies

• It is not affected by any vaccines

• It is less contagious than other variants

• It only affects people with underlying conditions

What is the impact of being fully vaccinated against the Delta variant?

• It provides a significant increase in immunity

• It makes individuals more susceptible

• It offers no additional protection

• It only protects against mild symptoms

What is contributing to the current surge in COVID-19 cases according to American health officials?

• Those who have recovered from COVID-19

• Fully vaccinated individuals

• People with booster shots

• Unvaccinated individuals